Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 438

2.
5.

Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma.

Kushitani K, Takeshima Y, Amatya VJ, Furonaka O, Sakatani A, Inai K.

Pathol Int. 2007 Apr;57(4):190-9.

PMID:
17316414
6.

Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma.

Pan CC, Chen PC, Chou TY, Chiang H.

Hum Pathol. 2003 Nov;34(11):1155-62.

PMID:
14652817
7.
9.
10.
11.

Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study.

Lucas DR, Pass HI, Madan SK, Adsay NV, Wali A, Tabaczka P, Lonardo F.

Histopathology. 2003 Mar;42(3):270-9.

PMID:
12605647
12.
14.

Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms.

Attanoos RL, Dojcinov SD, Webb R, Gibbs AR.

Histopathology. 2000 Sep;37(3):224-31.

PMID:
10971698
16.
17.
18.

Novel marker D2-40, combined with calretinin, CEA, and TTF-1: an optimal set of immunodiagnostic markers for pleural mesothelioma.

Mimura T, Ito A, Sakuma T, Ohbayashi C, Yoshimura M, Tsubota N, Okita Y, Okada M.

Cancer. 2007 Mar 1;109(5):933-8.

20.

Primary thymic epithelial tumours of the pleura mimicking malignant mesothelioma.

Attanoos RL, Galateau-Salle F, Gibbs AR, Muller S, Ghandour F, Dojcinov SD.

Histopathology. 2002 Jul;41(1):42-9.

PMID:
12121236
Items per page

Supplemental Content

Support Center